Search for: "Mylan Pharmaceuticals, Inc"
Results 201 - 220
of 497
Sorted by Relevance
|
Sort by Date
4 Dec 2012, 6:30 am
Related posts:Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
8 Dec 2021, 8:47 am
Mylan Pharmaceuticals Inc. [read post]
1 Feb 2022, 1:22 pm
Mylan Pharmaceuticals Inc., Docket No. 21-01729 (Fed. [read post]
5 Sep 2012, 3:30 pm
Pioglitazone comes from Mylan Pharmaceuticals. [read post]
7 Feb 2019, 5:36 pm
In Momenta Pharmaceuticals, Inc. v. [read post]
14 Apr 2015, 8:34 pm
Apotex Inc. v. [read post]
14 Apr 2015, 8:34 pm
Apotex Inc. v. [read post]
29 Aug 2011, 5:53 am
After the Federal Circuit's decision in Thereasense, Inc. v. [read post]
28 Aug 2009, 8:11 am
Mylan Pharmaceuticals Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
7 May 2013, 12:27 pm
Mylan Techs. [read post]
4 Nov 2008, 6:18 am
Digitek, also known as digitalis or digoxin, is a prescription drug that was recalled from the market in April of 2008 by manufacturers Actavis Totowa, LLC; Actavis, Inc.; Actavis US; Mylan, Inc.; Mylan Pharmaceuticals, Inc.; Mylan Laboratories, Inc.; Mylan Bertek Pharmaceuticals; and UDL Laboratories, Inc. [read post]
7 Dec 2021, 8:33 am
Mylan Pharms. [read post]
17 Jul 2017, 9:41 am
Par Pharm., Inc. v. [read post]
6 Nov 2023, 8:35 am
Mylan Pharmaceuticals Inc., No. 2022-1889 (Fed. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
18 Aug 2017, 2:15 pm
Mylan Inc., et al.. [read post]
26 Feb 2014, 5:37 pm
Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
27 Dec 2012, 3:47 pm
Mylan Pharmaceuticals, Inc., 2012 WL 170143, at *5 (S.D. [read post]
